Metavesco, Inc. (MVCO) stock: key figures, P/E, revenue and dividend
Financials · United States
Metavesco, Inc. financials
| Fiscal year | 2023 |
|---|---|
| Revenue | 127,087.00 USD |
| EBIT | -475,413.00 USD |
| Net income | -572,845.00 USD |
| Diluted EPS – continuing operations | -0.01 USD |
Full history since 2015, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Metavesco, Inc.
Metavesco, Inc. is no longer investing. It seeks to invest in small private and public companies. The firm does not invest in start-ups, turnaround situations, oil or gas exploration, real estate development, and direct lending businesses. The firm prefers to provide, with a more than five year term with flexible amortization between $1 million and $3 million as senior debt financing. The firm co-invests in case of large investments and prefers to structure its investments as debt with attached warrants on common stock or as senior debts. The firm prefers equity participation when it provides subordinate loans and a collateral of assets while providing senior debt financing. Metavesco, Inc. was founded in 1993 and is based in Virginia Beach, Virginia.
More stocks
- Regen BioPharma Inc (RGBPP)
- ESS Tech, Inc. (GWH)
- Onconetix, Inc. (ONCO)
- SmartKem, Inc. (SMTK)
- Livento Group, Inc. (LIVG)
- BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
- Valion Bio, Inc. (VBIO)
- ALKALINE WATER Co INC (WTER)
- Telvantis, Inc. (RDAR)
- ESPORTS ENTERTAINMENT GROUP, INC. (GMBLP)
- Wellchange Holdings Company Limited (WCT)
- Resonate Blends, Inc. (KOAN)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.